Mylan N Return On Equity

MYL -- USA Stock  

USD 19.03  0.14  0.73%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Mylan N Return On Equity Analysis

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how effecently a company utilizes investments to generate income.
Return on Equity 
Net Income 
Total Equity 
More About Return On Equity | All Equity Analysis
Mylan N Return On Equity  =
Mylan N ValuationFundamentalsBuy or Sell

Return On Equity Over Time Pattern

 Mylan N Return on Average Equity 

About Return On Equity

For most industries Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Compare to competition

Mylan N Return On Equity Assessment

Shareholders Equity
Based on latest financial disclosure Mylan N V has Return On Equity of 1.92%. This is 108.01% lower than that of the Healthcare sector, and 448.57% higher than that of Drug Manufacturers - Specialty & Generic industry, The Return On Equity for all stocks is 719.35% lower than the firm.

Did you try this?

Run Price Exposure Probability Now


Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Mylan N current financial ratios